Abstract | BACKGROUND: STUDY DESIGN: Two separate 1-year Phase 3 clinical programs were conducted using similar study designs. The percentages of subjects reporting bleeding and spotting using electronic diaries for each 91-day cycle were compared. RESULTS: Scheduled bleeding with the EE regimen was less than that reported with the regimen utilizing placebo during Days 85-91, with significant differences noted for all four 91-day cycles. Unscheduled bleeding decreased more quickly with the 91-day regimen containing low-dose EE in place of placebo, with significant differences noted during the third cycle. CONCLUSIONS: This cross-study comparison suggests that the administration of low-dose estrogen in place of placebo in a 91-day extended regimen OC improves the bleeding profile.
|
Authors | Andrew M Kaunitz, David J Portman, Howard Hait, Kathleen Z Reape |
Journal | Contraception
(Contraception)
Vol. 79
Issue 5
Pg. 350-5
(May 2009)
ISSN: 1879-0518 [Electronic] United States |
PMID | 19341846
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Contraceptives, Oral, Hormonal
- Estrogens
- Seasonale
- Ethinyl Estradiol
- Levonorgestrel
- Ethinyl Estradiol-Norgestrel Combination
|
Topics |
- Adult
- Clinical Trials as Topic
- Contraceptives, Oral, Hormonal
(administration & dosage)
- Estrogens
(administration & dosage, adverse effects)
- Ethinyl Estradiol
(administration & dosage, adverse effects)
- Ethinyl Estradiol-Norgestrel Combination
(administration & dosage, adverse effects)
- Female
- Humans
- Levonorgestrel
(administration & dosage, adverse effects)
- Menstruation
(drug effects)
- Metrorrhagia
(chemically induced)
- Retrospective Studies
- Young Adult
|